Home › Therapeutic areas › Neurology › Bipolar Disorder

Bipolar Disorder (7 companies)

Companies with an active program in Bipolar Disorder.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ANRO Alto Neuroscience Neurology 1 Phase 2 $999M 6
GHRS GH Research NeurologyWomen's Health 1 Phase 2 $1.25B 4
LBRX LB Pharmaceuticals Neurology 1 Phase 3 $1.30B 3
NRXP NRX Pharmaceuticals Neurology Rare 1 Approved $109M 11
RVPH Reviva Pharmaceuticals CardiovascularDermatology+3 Rare 1 Phase 3 $4.7M 11
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 2 Approved $230M 27
XENE Xenon Pharmaceuticals Neurology Rare 1 NDA Submitted $3.81B 9